HHGA
GILD icon

Halbert Hargrove Global Advisors’s Gilead Sciences GILD Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.12K Buy
64
+13
+25% +$1.71K ﹤0.01% 322
2026
Q1 		$7.11K Sell
51
-25
-33% -$3.5K ﹤0.01% 306
2025
Q4 		$9.33K Sell
76
-122
-62% -$14.8K ﹤0.01% 298
2025
Q3 		$22K Buy
198
+122
+161% +$13.9K ﹤0.01% 240
2025
Q2 		$8.43K Sell
76
-68
-47% -$7.24K ﹤0.01% 239
2025
Q1 		$16.1K Buy
144
+68
+89% +$7.02K ﹤0.01% 214
2024
Q4 		$7.02K Buy
+76
New +$6.84K ﹤0.01% 246
2014
Q3 		– Sell
-3,257
Closed -$270K – 153
2014
Q2 		$270K Sell
3,257
-849
-21% -$66.1K 0.08% 92
2014
Q1 		$291K Sell
4,106
-507
-11% -$39.8K 0.09% 89
2013
Q4 		$346K Sell
4,613
-409
-8% -$28.5K 0.11% 71
2013
Q3 		$316K Sell
5,022
-210
-4% -$12.6K 0.1% 74
2013
Q2 		$268K Buy
+5,232
New +$273K 0.1% 90

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Halbert Hargrove Global Advisors's GILD Position: Q2 2026 in Review

Halbert Hargrove Global Advisors increased its Gilead Sciences (GILD) stake by 25% in Q2 2026, buying an estimated $1.71K and bringing the position to 64 shares worth $8.12K. The position accounts for ﹤0.01% of the portfolio, ranked #322.

Halbert Hargrove Global Advisors first reported a position in GILD in Q2 2013 and has held it in 12 quarters since. The position peaked at $346K in Q4 2013. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Halbert Hargrove Global Advisors held 64 shares of Gilead Sciences worth $8.12K as of Q2 2026.
  • Halbert Hargrove Global Advisors bought 13 Gilead Sciences shares in Q2 2026, an estimated $1.71K.
  • Gilead Sciences made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #322 holding.
  • Halbert Hargrove Global Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 12 quarters since.
  • Halbert Hargrove Global Advisors's Gilead Sciences position peaked at $346K in Q4 2013.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.